This study aimed to identify somatic mutations most commonly found in well differentiated thyroid cancers, which includes BRAF and RAS. Using a PCR based approach in a large cohort, Moses et al. suggested BRAF and RAS mutation testing of FNAB could improve the rate of definitive surgical management [2]. Here, BRAF is linked to thyroid cancer.